What we found in our predictive model for opioid use disorder is that behavioral health conditions are actually the best predictors of who is going to traverse into opioid use disorder, explained Elizabeth Stringer, PhD, chief science and clinical officer of axialHealthcare.
What we found in our predictive model for opioid use disorder is that behavioral health conditions are actually the best predictors of who is going to traverse into opioid use disorder, explained Elizabeth Stringer, PhD, chief science and clinical officer of axialHealthcare.
Transcript:
Are veterans at a higher risk of opioid abuse than other demographics, and if so, why?
The VA [Veterans Administration] has been a great partner and a lot of wonderful research has come out of the VA when it comes to pain management and opioid use disorder. The military population is at increased risk— more than the general population– of traversing into opioid use disorder.
One of the reasons for that is, of course, the stress and exposure to things that most everyday Americans aren’t exposed to. What we found in our predictive model for opioid use disorder is that behavioral health conditions are actually the best predictors of who is going to traverse into opioid use disorder— who’s going to get diagnosed with opioid use disorder.
The military population has a high percentage of their population that have stress disorders, post-traumatic stress disorders, anxiety, and oftentimes depression. So, it’s typically around the behavioral health aspects that make this population vulnerable. Pain and opioid use disorder are both biopsychosocial conditions, so it’s not just the bio part or the behavioral health part, but also the social part too.
Unfortunately, as a society, we don’t always do a great job of socially supporting our veterans as they come back to America. Again, the sort of social component makes them more vulnerable to traversing into opioid use disorder.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen